A method is described for the determination of bromides in biological samples using neutron activation analysis. The specificity of this method eliminates sources of interference from other halogens and contamination of analytical agents with extraneous bromide. In duplicate samples of blood, at varying concentrations of potassium bromide, the mean difference was 4.5% ±1.95 and the mean of the SD of twelve duplicate estimations was ±0.87. The 95% confidence limit of a single estimation was ±1.6%.
Bromides are normal constituents of the human body, being present in ingested sodium chloride and food. The conventional way of measuring serum bromide is based on the colorimetric measurement of gold bromide formed by the reaction of this halide with gold chloride. Ucko (1936) and Conway and Flood (1936) have estimated the normal content of bromides in human blood and found that it was between 1 and 10 yug/ml. However, the gold chloride method has been reported to be insensitive and nonspecific (Wright, Smith and Black, 1958) . Hunter (1953) proposed the use of a bromate-rosaniline reaction to estimate bromide in body fluids. This is sensitive and specific but requires an incineration step with alkali.
Neutron activation analysis is a highly sensitive and specific method of detecting elements in biological material. Lyon (1966) gives the sensitivity for Br estimation as <0.002 ng. Samples of blood or tissue are placed in a source of neutrons to produce radioactive isotopes which can be separated chemically, positively identified and quantitated by plotting their characteristic gamma spectrum. Bowen (1959) and Belkas and Souliotis (1966) have applied this technique to quantitate bromides in biological samples. There is no exposure of the patient to radiation since the isotopes are produced after the samples are taken.
It is known that debromination of halothane takes place since Rehder and colleagues (1967) have measured increased amounts of bromide excreted in urine after administration of halothane anaesthetics.
Since one bromide ion is present in each molecule of halothane, the amount of bromide liberated can be used to quantitate metabolism of halothane. This paper describes a specific method of estimating bromide able to detect minor variations in small samples of blood.
MATERIAL AND METHODS

Irradiation of samples.
Blood samples of 0.5 ml each were put in polyethylene snap-closure tubes of 1 ml capacity. These were stoppered and fused with a carbon-tipped soldering iron. The carbon tip was used in order to avoid tracer contamination from copper. The sealed containers were checked for leakage by immersion in boiling water. Standards of 200 /*g of bromide as potassium bromide in 0.5 ml of water were similarly sealed in polyethylene tubes. The tubes containing samples and standards were packed in aluminium cans, each containing four blood samples and one standard. These were sent for activation at the Universities Research Reactor at Risley, Lancashire, England. The cans were irradiated in a thermal neutron flux of 0.16 x 10 11 neutrons/cm'/sec for periods varying from 6 to 1\ hr. After removal from the neutron source, the relatively long half-life of "Br (36.87 hr) allowed time for chemical separation and counting. The samples were returned to liverpool on the day after irradiation and left for a further 24 hr so that short-lived isotopes such as 80 Br (half-life 18 min) and Standard solution contained 0.04% bromide as potassium bromide (Analar). 
Concentrated sulphuric acid (Analar
Apparatus.
This is shown in figure 1 and consisted of a conical flask through which a continuous flow of air driven by cylinder or pump was gently bubbled through the blood sample to carry liberated volatile elements to be trapped on a column of glass beads bathed in sodium hydroxide solution. Chemical separation of bromide.
Since blood contains elements such as sodium and potassium in larger amounts than bromide these become radioactive and cause interference with counting procedures. This necessitates chemical separation and isolation of bromide as a precipitate in the form of silver bromide. To minimize loss of 82 Br present in trace amounts in the 0.5 ml sample of blood a non-radioactive carrier, 20 mg Br as KBr, was added to the blood sample in the conical flask. Acid hydrolysis of the sample was achieved by the addition of 5 ml sulphuric acid. Hydrogen peroxide 5 ml was added to help liberate free bromine which was carried by the stream of air to the column of glass beads to be converted to sodium bromide. Finally, sodium nitrite 5 ml was added to the flask which was then heated to ensure complete removal of bromine. The fluid in the column of glass beads was transferred to a 100-ml separating funnel, and the glass beads washed three times with 10 ml of halogen-free distilled water. The contents of the separating funnel were oxidized by the addition of 4 ml nitric acid, and potassium permanganate in excess. This was added drop by drop until the pink permanganate colour was just visible after shaking. This solution was extracted three times with 10 ml of carbon tetrachloride to remove the bromine from the aqueous phase. The yellow organic bottom layer was collected in a second separating funnel. The bromine in the organic phase was then reduced by the addition of 10 ml distilled water to which had been added 10 drops of ammonia. The separating funnel was well shaken until the yellow colour disappeared. This colourless top aqueous layer was added to a test tube containing 4 ml silver nitrate and 4 ml nitric acid. The yellow precipitate of silver bromide was incubated in a warm water bath for 10-15 min to encourage the growth of large crystals. The precipitated silver bromide was collected using glass filter paper discs. These were dried overnight in a dessicator and weighed. It was then possible to calculate the recovery of carrier bromide which contained a proportion of the 82 Br present in the original blood sample.
Determination of radioactivity.
The glass filter paper discs containing the precipitated silver bromide, were mounted on aluminium planchettes and were counted with a thailiumactivated sodium iodide crystal (7.5 x 7.5 cm) detector and a gamma ray spectrometer. The source to detector distance was a few millimetres. The pulses were analysed by a Laben 512-channel analyser utilizing 128 channels to cover the energy range up to c. 2500 keV. The photopeak area was printed with an XY plotter, and the counts were also read on a memory tape. The gamma spectrum displayed on the monitor screen of the spectrometer ( fig. 2) shows in trace 1 the single peak 0.67 meV of Cesium-137 used to calibrate the equipment. Bromine-82 has seven Y peaks ranging from 0.54 to 1.45 meV. In trace 2, two main peaks visible have energies of 0.54 and 0.77 meV. The total number if counts associated with these peaks was obtained from the memory tape and used to calculate the photopeak area which was also plotted on an XY plotter. The photopeak area was proportional to the amount of bromide present in the sample when compared with peaks obtained from bromide of known amount irradiated in control tubes exposed to the same neutron flux.
In trace 3, similar small peaks were observed in a preoperative sample of blood subjected to the same treatment and indicates the quantity of bromide present in the patient blood at this time. Traces 3, 4 and 5 were obtained from samples of blood taken from the patient at different times following exposure to halothane. It can be seen that the peak heights vary, depending upon the time after administration of halothane.
Calculation of bromide concentrations.
The specific activity of 8J Br present in the precipitated silver bromide is in proportion to the concentration of bromide in the irradiated sample of blood to which the carrier bromide was added. This allows correction to compensate for low recovery of bromide during chemical separation. The percentage recovery of the carrier bromide as silver bromide varied between 63.0 and 88.3% with a mean recovery of 74.7%. There was no significant differences in the recovery ratio with either potassium bromide or blood samples.
RESULTS
Accuracy of bromide estimations.
In order to determine the reprodudbility and accuracy of this method, four concentrations of potassium bromide were prepared and quadruple samples irradiated. The results are shown in table I. It can be seen that the percentage recovery was greater at the lower concentration range but that at higher concentrations the SD is lower and there was thus less variation in recovery.
In duplicate samples of venous blood obtained from patients who had received halothane it was found that at varying concentrations of bromide reproducibility was good, with a mean difference of 4.5 ±1.95% (table II) . The mean of the standard deviations of duplicate estimations was 0.87. The 95% confidence limits of a single estimation was ±1.6%.
DISCUSSION
The use of activation analysis eliminates the errors associated with impurity of analytical reagents. Hunter and Goldspink (1954) found hypochlorite solutions to be too grossly contaminated with bromate to be of use as analytical reagents. This is due to the bromine content of the chlorine from which the hypochlorite is made. Other sources of extraneous bromide can come from the use of activated charcoal powder to remove pigments in colorimetric methods. Underwood (1967) reported that charcoal was found to contain significant quantities of bromide. Errors associated with neutron activation analysis are different from those of conventional chemical methods. The standard used for comparison must receive the same neutron flux as the unknown samples. This was achieved by irradiating the standard and no more than four unknowns in each aluminium can in an area of the reactor known to have a homogeneous flux.
Another possible source of error was failure to achieve equilibration between the "Br in the blood sample and the carrier bromide. Thorough mixing was assured by bubbling with air and the agitation of the chemical reactions associated with heating in the distillation flask, making this unlikely in this procedure.
Estimation of bromides in human blood by neutron activation analysis was first performed by Bowen (1959) . Following chemical extraction of bromides, he obtained a mean yield of 76% which agrees with our figure of 74.7%. The greatest loss of bromide was found to occur during potassium permanganate oxidation. Bowen (1959) calculated this to be 15.2%. It was thus important to add just sufficient permanganate to give complete oxidation and to avoid unnecessary excess. Belkas and Souliotis (1966) used this method to estimate bromides in urine. Their results were reproducible with an error of less than ±3%. Neither of these studies, however, reported the accuracy of recovery from samples containing known amounts of bromide. A knowledge of the sensitivity and specificity are two essential factors in evaluating an analytical method. Using activation analysis with an isotope dilution technique allows determination of low bromide concentrations in stroll samples of blood. The use of a gamma spectrometer following chemical separation of bromide makes this method of analysis highly specific for the determination of bromides. Our results show that the method described is reliable and reproducible and able to cover the range of bromide produced during and after halothane anaesthesia. DETERMINATION 
RESUMEN
Es descrito un m^todo para la determinaci6n de bromuros en muestras biol6gicas utiUzando el anaUisis por activaddn de neutrones. La especificidad de este mitodo elimina las fuentes de interferencia por otros hal6genos y la contaminaci6n de los agentes analiticos con bromuros extraflos. En muestras duplicadas de sangre a concentraciones variables de bromuro pota^ico la diferencia media fue de 4,5% ±1,95 y la media de la SD de 12 evaluaciones duplicadas fue de ±0,87. El limite de confianza al 95% para una evahiaci6n aislada fue de ±1,6%.
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